LivaNova Plc (LIVN)
62.19
-1.34
(-2.11%)
USD |
NASDAQ |
Mar 20, 16:00
62.19
0.00 (0.00%)
After-Hours: 20:00
LivaNova Research and Development Expense (Quarterly) : 51.50M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NovoCure Ltd. | 60.90M |
| Alphatec Holdings, Inc. | 22.28M |
| AtriCure, Inc. | 22.74M |
| Tandem Diabetes Care, Inc. | 46.07M |
| iRhythm Holdings, Inc. | 21.05M |